The MESA method uses ecological theory to map cellular diversity and spatial patterns in tissues, offering new insights into disease progression.

The nanoparticle-based vaccine shows promise against many variants of SARS-CoV-2, as well as related sarbecoviruses that could jump to humans.

MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.

The building will serve as a hub for research on the development of immunology-based treatments.

Using a DNA-based scaffold carrying viral proteins, researchers created a vaccine that provokes a strong antibody response against SARS-CoV-2.

The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.

In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.

The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.

By applying a language model to protein-drug interactions, researchers can quickly screen large libraries of potential drug compounds.

The targeted approach eliminated tumors in mice, with minimal side effects.